<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/"><channel><title>心血管高季刊</title><link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;utm_medium=rss&amp;ff=20230726085455&amp;utm_source=Chrome&amp;ut m _content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_campaign=pubmed-2&amp;v=2.17.9。邮政6 +86293ac<description>心血管高季刊：PubMed 的最新结果</description><atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;utm_medium=rss&amp;ff=20230726085455&amp;utm_source=Chrome&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_campaign=pubmed-2&amp;v=2.17.9.post6+86293ac" rel="self"></atom:link><docs> http://www.rssboard.org/rss-specification</docs><generator> PubMed RSS 源 (2.17.9.post6+86293ac)</generator><language> zh</language><lastbuilddate> 2023 年 7 月 26 日星期三 12:54:56 +0000</lastbuilddate><pubDate> Wed, 26 Jul 2023 06:00:00 -0400</pubDate><ttl> 120</ttl><item><title>细丝蛋白 C 与肌动蛋白的相互作用对于心脏发育和功能至关重要</title><link/>https://pubmed.ncbi.nlm.nih.gov/37492967/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff = 20230726085455&amp;v=2.17.9.post6+86293ac<description>结论：我们的数据强烈支持 FLNC 通过与肌动蛋白、ITGB1、γ-SAG 和心肌细胞中其他相关蛋白的相互作用，作为肌动蛋白丝和 ECM 之间的桥梁发挥重要作用。FLN-肌动蛋白相互作用的破坏可能导致肌动蛋白分离来自细胞外基质的细丝，最终损害正常的心脏发育和功能。这些发现还为与 FLNC 遗传变异相关的心肌病的潜在机制提供了见解...... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Circ Res. 2023 年 7 月 26 日。doi：10.1161/CIRCRESAHA.123.322750。印刷前在线。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">背景：FLNC（细丝蛋白 C）是 FLN 家族的成员，主要在横纹肌中表达，在桥接心肌细胞中的细胞骨架和 ECM（细胞外基质）方面发挥着至关重要的作用，从而维持心脏的完整性和功能。 FLNC 的结合域）已在心肌病患者中得到鉴定，但肌动蛋白结合能力对哺乳动物心脏中 FLNC 功能的精确贡献仍知之甚少。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：我们对小鼠 FLNC 的 3 维结构进行了计算机分析，以确定 ABD 内对于 FLNC 肌动蛋白结合能力至关重要的关键氨基酸残基。随后，我们进行了免疫共沉淀和免疫荧光测定，以验证计算机结果和评估这些突变对与其他结合伙伴的相互作用以及 FLNC 的亚细胞定位的影响。此外，我们生成并分析了敲入小鼠模型，其中 FLNC-肌动蛋白相互作用被这些突变完全破坏。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：我们的研究结果表明，F93A/L98E 突变完全破坏了 FLNC-肌动蛋白相互作用，同时保留了 FLNC 与其他结合伙伴 ITGB1（β1 整联蛋白）和 γ-SAG（γ-肌聚糖）相互作用的能力，以及维持 FLNC 亚细胞定位。胚胎心肌细胞中FLNC-肌动蛋白相互作用导致胚胎致死和心脏发育缺陷，包括心室壁畸形和心肌细胞增殖减少。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：我们的数据强烈支持 FLNC 通过与肌动蛋白、ITGB1、γ-SAG 和心肌细胞中其他相关蛋白的相互作用，作为肌动蛋白丝和 ECM 之间的桥梁发挥重要作用。FLN-肌动蛋白相互作用的破坏可能导致肌动蛋白分离这些发现还为了解与 FLNC ABD 遗传变异和其他机制相关的潜在心肌病提供了见解。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37492967/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230726085455&v=2.17.9.post6+86293ac">37492967</a> | DOI： <a href=https://doi.org/10.1161/CIRCRESAHA.123.322750>10.1161/CIRCRESAHA.123.322750</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37492967</guid><pubDate> Wed, 26 Jul 2023 06:00:00 -0400</pubDate><dc:creator>周小海</dc:creator><dc:creator>西芳</dc:creator><dc:creator>Sujay S Ithychanda</dc:creator><dc:creator>吴同斌</dc:creator><dc:creator>谷玉苏</dc:creator><dc:creator>陈超</dc:creator><dc:creator>王丽</dc:creator><dc:creator>朱利叶斯·博戈莫洛瓦斯</dc:creator><dc:creator>秦俊</dc:creator><dc:creator>陈菊</dc:creator><dc:date>2023-07-26</dc:date><dc:source>流通研究</dc:source><dc:title>细丝蛋白 C 与肌动蛋白的相互作用对于心脏发育和功能至关重要</dc:title><dc:identifier>下午：37492967</dc:identifier><dc:identifier> doi:10.1161/CIRCRESAHA.123.322750</dc:identifier></item><item><title> T-Cell MyD88 是一种通过调节 T 细胞激活来调节心脏纤维化的新型调节剂</title><link/>https://pubmed.ncbi.nlm.nih.gov/37492941/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff = 20230726085455&amp;v=2.17.9.post6+86293ac<description>结论：我们的结果概述了 MyD88 在限制 T 细胞激活方面的新颖内在作用，该作用对于心脏适应应激过程中调节心脏炎症至关重要。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Circ Res. 2023 年 7 月 26 日。doi：10.1161/CIRCRESAHA.123.323030。印刷前在线。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">背景：心力衰竭中心脏炎症的特征是存在损伤相关分子模式、骨髓细胞和 T 细胞，衔接蛋白 MyD88（骨髓分化反应 88）。这些诱导激活有效的抗原呈递细胞，从而激活 T 细胞通过 TCR（T 细胞受体）。T 细胞激活导致趋心性、心脏成纤维细胞转化和适应不良心脏重塑 T 细胞依赖 TCR 信号传导来实现效应功能和生存，同时表达 MyD88 和损伤相关分子模式受体，它们在 T 细胞激活和心脏炎症中的作用尚不清楚。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：我们对 T 细胞中缺乏 MyD88 的小鼠进行横向主动脉缩窄，并分析重塑、收缩功能、存活和 T 细胞激活。我们在转录本和蛋白质水平上对 WT 与<i>Myd88</i> <sup><i>-/-</i></sup>小鼠 T 细胞进行了分析，并进行了多项功能性研究。化验。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：单细胞 RNA 测序数据集分析显示，MyD88 在小鼠和人类心脏 T 细胞中表达。T 细胞中 MyD88 缺失导致心脏 T 细胞浸润和纤维化水平增加，以响应主动脉横缩。与 WT 相比，TCR 激活的<i>Myd88</i> <sup><i>-/-</i></sup> T 细胞在转录本和蛋白质水平上增加了促炎信号传导，导致 T 细胞效应功能增加，例如粘附、跨内皮细胞迁移和心脏成纤维细胞激活。发现 MyD88 通过 TCR 依赖性而非 TLR 依赖性信号传导调节 T 细胞活化和存活。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：我们的结果概述了 MyD88 在限制 T 细胞激活方面的新颖内在作用，该作用对于心脏适应应激过程中调节心脏炎症至关重要。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37492941/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230726085455&v=2.17.9.post6+86293ac">37492941</a> | DOI： <a href=https://doi.org/10.1161/CIRCRESAHA.123.323030>10.1161/CIRCRESAHA.123.323030</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37492941</guid><pubDate> Wed, 26 Jul 2023 06:00:00 -0400</pubDate><dc:creator> ——亚伯拉罕·L·拜尔</dc:creator><dc:creator>萨沙·斯莫尔戈夫斯基</dc:creator><dc:creator>恩贾布洛·恩文亚马</dc:creator><dc:creator>安娜·埃尔南德斯·马丁内斯</dc:creator><dc:creator>库尔吉特·考尔</dc:creator><dc:creator>凯瑟琳·苏尔卡</dc:creator><dc:creator>朱德·阿姆鲁特</dc:creator><dc:creator>马克·阿罗诺维茨</dc:creator><dc:creator>科里·拉文</dc:creator><dc:creator>施鲁蒂·夏尔马</dc:creator><dc:creator>皮拉尔·阿尔凯德</dc:creator><dc:date>2023-07-26</dc:date><dc:source>流通研究</dc:source><dc:title>T-Cell MyD88 是一种通过调节 T 细胞激活来调节心脏纤维化的新型调节剂</dc:title><dc:identifier>下午：37492941</dc:identifier><dc:identifier> doi:10.1161/CIRCRESAHA.123.323030</dc:identifier></item><item><title>使用冠状动脉内 OCT 和深度免疫表型分析揭示 ACS 病理生理学</title><link/>https://pubmed.ncbi.nlm.nih.gov/37491589/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff = 20230726085455&amp;v=2.17.9.post6+86293ac<description>没有摘要</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Nat Rev Cardiol. 2023 Jul 25. doi: 10.1038/s41569-023-00915-w. 印刷前在线。</p><p><b>无摘要</b></p><p style="color: lightgray">PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37491589/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230726085455&v=2.17.9.post6+86293ac">37491589</a> | DOI： <a href=https://doi.org/10.1038/s41569-023-00915-w>10.1038/s41569-023-00915-w</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37491589</guid><pubDate> Wed, 26 Jul 2023 06:00:00 -0400</pubDate><dc:creator>詹妮弗·哈曼</dc:creator><dc:date>2023-07-26</dc:date><dc:source> 《自然》评论、心脏病学</dc:source><dc:title>使用冠状动脉内 OCT 和深度免疫表型分析揭示 ACS 病理生理学</dc:title><dc:identifier>下午：37491589</dc:identifier><dc:identifier> doi:10.1038/s41569-023-00915-w</dc:identifier></item><item><title>在成功的癌症免疫治疗过程中，个体 T 细胞受体靶向多种肿瘤相关抗原</title><link/>https://pubmed.ncbi.nlm.nih.gov/37490916/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff = 20230726085455&amp;v=2.17.9.post6+86293ac<description>肿瘤浸润淋巴细胞 (TIL) 治疗后，免疫系统的 T 细胞可以靶向肿瘤并清除实体癌。我们使用组合肽库和蛋白质组数据库来揭示持久性癌症特异性 T 细胞受体 (TCR) 的抗原特异性，如下所示：成功的 TIL 疗法治疗 IV 期恶性黑色素瘤。值得注意的是，单个 TCR 可以通过 HLA A^(*)02:01 限制性表位 EAAGIGILTV、LLLGIGILVL 和...靶向多种不同的肿瘤类型。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> <b>Cell</b> . 2023 年 7 月 19 日：S0092-8674(23)00696-7.doi: 10.1016/j.cell.2023.06.020.打印前在线。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">肿瘤浸润淋巴细胞 (TIL) 治疗后，免疫系统的 T 细胞可以靶向肿瘤并清除实体癌。我们使用组合肽库和蛋白质组数据库来揭示持久性癌症特异性 T 细胞受体 (TCR) 的抗原特异性，如下所示：成功的 TIL 疗法治疗 IV 期恶性黑色素瘤。值得注意的是，单个 TCR 可以通过分别来自 Melan A、BST2 和 IMP2 的 HLA A <sup>*</sup> 02:01 限制性表位 EAAGIGILTV、LLLGIGILVL 和 NLSALGIFST 靶向多种不同的肿瘤类型。对所有三种抗原的研究揭示了共享 xxxA/GI/LGIxxx 识别基序的重要性。多表位靶向允许单个 T 细胞同时以多种方式攻击癌症。与传统 T 细胞相比，这种“多管齐下”的 T 细胞对癌细胞表现出卓越的识别能力细胞识别单个表位，使它们成为未来免疫疗法开发的有吸引力的候选者。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37490916/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230726085455&v=2.17.9.post6+86293ac">37490916</a> | DOI： <a href=https://doi.org/10.1016/j.cell.2023.06.020>10.1016/j.cell.2023.06.020</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37490916</guid><pubDate> Tue, 25 Jul 2023 06:00:00 -0400</pubDate><dc:creator>加里·道尔顿</dc:creator><dc:creator>克里斯蒂娜·鲁斯</dc:creator><dc:creator>亚伦·沃尔</dc:creator><dc:creator>芭芭拉·佐莫莱</dc:creator><dc:creator>瓦伦蒂娜·比安奇</dc:creator><dc:creator>莎拉·A·E·加洛韦</dc:creator><dc:creator>萨缪尔·哈桑博士</dc:creator><dc:creator>西奥·莫兰</dc:creator><dc:creator>海军陆战队·E·卡约</dc:creator><dc:creator>——汉娜·托马斯</dc:creator><dc:creator>萨拉·西克</dc:creator><dc:creator>谭丽蓉</dc:creator><dc:creator>安娜·富勒</dc:creator><dc:creator>凯蒂·托普利</dc:creator><dc:creator>马特乌斯·勒古特</dc:creator><dc:creator>梅里姆·阿塔夫</dc:creator><dc:creator>——杰德·R·霍普金斯</dc:creator><dc:creator>埃纳斯·贝希里</dc:creator><dc:creator>乔安娜·扎布凯维奇</dc:creator><dc:creator>卡罗琳·阿尔瓦雷斯</dc:creator><dc:creator>安格拉德·劳埃德</dc:creator><dc:creator>——安布尔·罗杰斯</dc:creator><dc:creator>彼得·亨利</dc:creator><dc:creator>克里斯托弗·费根</dc:creator><dc:creator>奥利弗·奥特曼</dc:creator><dc:creator>史蒂芬·曼</dc:creator><dc:creator>——迈克尔·D·克劳瑟</dc:creator><dc:creator>Marco Donia更多</dc:creator><dc:creator>英格·玛丽·斯瓦内</dc:creator><dc:creator>大卫·K·科尔</dc:creator><dc:creator>保罗·E·布朗</dc:creator><dc:creator>皮埃尔·里兹卡拉</dc:creator><dc:creator>安德鲁·K·休厄尔</dc:creator><dc:date>2023-07-25</dc:date><dc:source>细胞</dc:source><dc:title>在成功的癌症免疫治疗过程中，个体 T 细胞受体靶向多种肿瘤相关抗原</dc:title><dc:identifier>下午：37490916</dc:identifier><dc:identifier> doi:10.1016/j.cell.2023.06.020</dc:identifier></item><item><title>从心电图图像检测左心室收缩功能障碍</title><link/>https://pubmed.ncbi.nlm.nih.gov/37489538/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff = 20230726085455&amp;v=2.17.9.post6+86293ac<description>结论：我们开发并外部验证了一种深度学习模型，该模型可以从心电图图像中识别左室收缩功能障碍。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>流通</b>。2023 年 7 月 25 日。doi：10.1161/CIRCULATIONAHA.122.062646。印刷前在线。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">背景：左心室 (LV) 收缩功能障碍与心力衰竭风险增加 8 倍以上以及过早死亡风险增加 2 倍相关。使用心电图信号筛查 LV 收缩功能障碍因其对临床医生的可用性而受到限制我们开发了一种基于深度学习的新型方法，可以使用心电图图像来筛查左心室收缩功能障碍。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：利用以多种不同格式绘制的 12 导联心电图以及 2015 年至 2021 年期间耶鲁纽黑文医院 15 天内记录的相应超声心动图数据，我们开发了一种卷积神经网络算法来检测 LV 射血分数 &lt;40% 的模型。在耶鲁纽黑文医院的临床环境中以及来自加利福尼亚州洛杉矶雪松西奈医疗中心、密苏里州奥塞奇比奇湖地区医院、德克萨斯州休斯顿纪念赫尔曼东南医院和圣路易斯卫理公会心脏病诊所的心电图图像上进行了外部验证。安东尼奥，德克萨斯州。此外，它在前瞻性巴西成人健康纵向研究中得到了验证。梯度加权类别激活映射用于定位心电图图像中的类别区分信号。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：总体而言，模型开发使用了 385 601 幅带有配对超声心动图的心电图。该模型在各种心电图图像格式和内部验证校准中表现出高辨别能力（接收操作特征下的面积 [AUROCs]，0.91；精确回忆曲线下的面积） [AUPRC]，0.55）；以及来自 Cedars Sinai 的外部心电图图像集（AUROC，0.90 和 AUPRC，0.53）、耶鲁纽黑文医院门诊诊所（AUROC，0.94 和 AUPRC，0.77）、湖区医院（AUROC，0.90 和心电图提示左心室收缩功能障碍预示着经胸超声心动图显示左心室收缩功能障碍的几率高出 27 倍以上（在保留组中，比值比为 27.5 [95% CI，22.3–33.9]）。前室和前间室导联（V <sub>2</sub>至 V <sub>3</sub> ），无论 ECG 布局如何，均对应于左心室。初始评估时 LV 射血分数≥40% 的个体的阳性 ECG 筛查与 3.9-未来发生左室收缩功能障碍的风险增加一倍（风险比，3.9 [95% CI，3.3-4.7]；中位随访时间，3.2 年）。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：我们开发并外部验证了一种深度学习模型，该模型可以从心电图图像中识别左室收缩功能障碍。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37489538/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230726085455&v=2.17.9.post6+86293ac">37489538</a> | DOI： <a href=https://doi.org/10.1161/CIRCULATIONAHA.122.062646>10.1161 / CIRCULATIONAHA.122.062646</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37489538</guid><pubDate> Tue, 25 Jul 2023 06:00:00 -0400</pubDate><dc:creator>维尔僧伽</dc:creator><dc:creator>阿拉什·纳尔格西</dc:creator><dc:creator>洛夫迪普·S·丁格拉</dc:creator><dc:creator>阿克谢·昆特</dc:creator><dc:creator>博巴克·J·莫尔塔扎维</dc:creator><dc:creator>安东尼奥·H·里贝罗</dc:creator><dc:creator>叶夫根尼娅·巴尼娜</dc:creator><dc:creator>奥卢瓦森·阿德奥拉</dc:creator><dc:creator>纳迪什·加尔格</dc:creator><dc:creator>辛西娅·勃兰特</dc:creator><dc:creator>——爱德华·J·米勒</dc:creator><dc:creator>安东尼奥·路易斯·J·里贝罗</dc:creator><dc:creator>埃里克·委拉斯开兹</dc:creator><dc:creator>卢安娜·贾蒂</dc:creator><dc:creator>Sandhi M Barreto更多</dc:creator><dc:creator>穆里洛·福帕</dc:creator><dc:creator>尼尔·袁</dc:creator><dc:creator>欧阳大卫</dc:creator><dc:creator>哈伦·M·克鲁霍尔兹</dc:creator><dc:creator>罗汉凯拉</dc:creator><dc:date>2023-07-25</dc:date><dc:source>循环</dc:source><dc:title>从心电图图像检测左心室收缩功能障碍</dc:title><dc:identifier>下午：37489538</dc:identifier><dc:identifier> doi:10.1161/循环AHA.122.062646</dc:identifier></item><item><title>绝经后妇女的绝经年龄、白细胞端粒长度和冠状动脉疾病</title><link/>https://pubmed.ncbi.nlm.nih.gov/37489536/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff = 20230726085455&amp;v=2.17.9.post6+86293ac<description>结论：更年期年龄越早，LTL 越短，尤其是自然绝经的女性。端粒加速缩短可能会增加与过早绝经相关的心血管风险。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Circ Res. 2023 年 7 月 25 日。doi：10.1161/CIRCRESAHA.123.322984。印刷前在线。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">背景：过早绝经是加速心血管衰老的危险因素，但其潜在机制仍不完全清楚。本研究调查了白细胞端粒长度（LTL）（细胞衰老和基因组不稳定的标志物）在过早绝经与心血管之间的关系中的作用。疾病。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：来自英国生物银行和妇女健康倡议的参与者，具有完整的生殖史和 LTL 测量值。初步分析使用多变量调整线性回归测试绝经年龄与 LTL 之间的关联。二次分析按妇科手术史对女性进行分层。孟德尔随机化用于推断 LTL 与自然绝经年龄之间的因果关系。多变量调整的 Cox 回归和中介分析测试了过早绝经和 LTL 与冠状动脉疾病的联合关联。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：本研究纳入了 130 254 名绝经后女性（英国生物库：n=122 224；女性健康倡议：n=8030），其中 4809 名（3.7%）在 40 岁之前经历过更年期。更早绝经与较短的 LTL 相关（meta -分析 ß=-0.02 SD/提前绝经 5 年 [95% CI，-0.02 至 -0.01]； <i>P</i> =7.2×10 <sup>-12</sup> )。（荟萃分析 ß=-0.04 SD/提前绝经 5 年 [ 95% CI，-0.04 至 -0.03]； <i>P</i> &lt;2.2×10 <sup>-16</sup> )，并且与激素治疗的使用无关。孟德尔随机化支持遗传上较短的 LTL 与自然绝经年龄较早之间的因果关系。LTL 和绝经年龄是与冠状动脉疾病的发生独立相关，中介分析表明，LTL 在绝经年龄与冠状动脉疾病的关联中具有微小但显着的中介作用。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：更年期年龄越早，LTL 越短，尤其是自然绝经的女性。端粒加速缩短可能会增加与过早绝经相关的心血管风险。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37489536/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230726085455&v=2.17.9.post6+86293ac">37489536</a> | DOI： <a href=https://doi.org/10.1161/CIRCRESAHA.123.322984>10.1161/CIRCRESAHA.123.322984</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37489536</guid><pubDate> Tue, 25 Jul 2023 06:00:00 -0400</pubDate><dc:creator>阿特·舒尔曼斯</dc:creator><dc:creator>中尾哲志</dc:creator><dc:creator>麦斯巴·乌丁</dc:creator><dc:creator>——惠特尼·霍恩斯比</dc:creator><dc:creator>施里耶·甘内什</dc:creator><dc:creator>阿拉丁 H 沙迪亚布</dc:creator><dc:creator>刘思敏</dc:creator><dc:creator>伯恩哈德·哈林</dc:creator><dc:creator>——克里斯桑德拉·L·舒菲尔特</dc:creator><dc:creator>玛格丽特·陶布</dc:creator><dc:creator>拉西卡·马蒂亚斯</dc:creator><dc:creator>查尔斯·库珀伯格</dc:creator><dc:creator>亚历山大·P·赖纳</dc:creator><dc:creator>亚历山大·G·比克</dc:creator><dc:creator>乔安·E·曼森</dc:creator><dc:creator>普拉迪普·纳塔拉詹</dc:creator><dc:creator>迈克尔·C·霍尼伯格</dc:creator><dc:date>2023-07-25</dc:date><dc:source>流通研究</dc:source><dc:title>绝经后妇女的绝经年龄、白细胞端粒长度和冠状动脉疾病</dc:title><dc:identifier>下午：37489536</dc:identifier><dc:identifier> doi:10.1161/CIRCRESAHA.123.322984</dc:identifier></item><item><title>更正：心脏病和中风统计数据 - 2023 年更新：美国心脏协会的报告</title><link/>https://pubmed.ncbi.nlm.nih.gov/37486999/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff = 20230726085455&amp;v=2.17.9.post6+86293ac<description>没有摘要</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>流通</b>. 2023 年 7 月 25 日；148(4):e4.doi: 10.1161/CIR.0000000000001167. Epub 2023 年 7 月 24 日。</p><p><b>无摘要</b></p><p style="color: lightgray">PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37486999/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230726085455&v=2.17.9.post6+86293ac">37486999</a> | DOI： <a href=https://doi.org/10.1161/CIR.0000000000001167>10.1161/CIR.0000000000001167</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37486999</guid><pubDate> Mon, 24 Jul 2023 06:00:00 -0400</pubDate><dc:date> 2023-07-24</dc:date><dc:source>循环</dc:source><dc:title>更正：心脏病和中风统计数据 - 2023 年更新：美国心脏协会的报告</dc:title><dc:identifier>下午：37486999</dc:identifier><dc:identifier>号码：10.1161/CIR.0000000000001167</dc:identifier></item><item><title> SGLT2 抑制剂对肾小管钠、水和氯稳态的影​​响及其在影响心力衰竭结局中的作用的批判性分析</title><link/>https://pubmed.ncbi.nlm.nih.gov/37486998/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff = 20230726085455&amp;v=2.17.9.post6+86293ac<description> SGLT2（钠-葡萄糖协同转运蛋白 2）抑制剂会干扰早期近端肾小管中葡萄糖和钠的重吸收，但任何随之而来的利尿钠或利尿作用的强度和持续时间是 SGLT2 上调程度和钠-葡萄糖协同转运蛋白 2 之间相互作用的结果。钠-氢交换器 3，下游代偿性肾小管机制被激活的程度，以及（可能）个体患者的容量设定点。全面审查和... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>流通</b>. 2023 年 7 月 25 日；148(4):354-372.doi: 10.1161/CIRCULATIONAHA.123.064346. Epub 2023 年 7 月 24 日。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> SGLT2（钠-葡萄糖协同转运蛋白 2）抑制剂会干扰早期近端肾小管中葡萄糖和钠的重吸收，但任何随之而来的利尿钠或利尿作用的强度和持续时间是 SGLT2 上调程度和钠-葡萄糖协同转运蛋白 2 之间相互作用的结果。钠-氢交换器 3，下游代偿性肾小管机制被激活的程度，以及（可能）个体患者的容量设定点。对现有研究的全面回顾和综合揭示了几种肾脏反应模式，这些模式在不同研究和临床环境中存在很大差异然而，常见的观察结果是，无论是单独使用还是与其他利尿剂联合使用，这些药物在几天或几周内都不会出现大量的急性或慢性利尿或尿钠排泄，从而防止进行性容量损失。尽管如此，研究发现，部分排泄在使用 SGLT2 抑制剂长期治疗期间，葡萄糖和锂（后者是近端钠重吸收的标志物）的持续存在表明，在近端小管水平上对这些药物的作用的药理学耐受性没有显着发生。这种持续的近端肾小管SGLT2 抑制剂的作用可以假设对容量稳态的内部设定点产生持久的改善，这在液体扩张期间可能变得具有临床重要性。然而，很难知道容量设定点是否与治疗相关的变化实际上发生或有助于这些药物降低主要心力衰竭事件风险的效果。这与 SGLT2 的存在或结合或这些药物对近端肾小管的作用无关。尽管如此，容量设置的变化SGLT2抑制剂介导的点可能与这些药物对心肌细胞的直接有利的分子和细胞效应协同作用，从而介导它们对心力衰竭的发展和临床过程的益处。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37486998/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230726085455&v=2.17.9.post6+86293ac">37486998</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC10358443/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230726085455&v=2.17.9.post6+86293ac">PMC10358443</a> | DOI： <a href=https://doi.org/10.1161/CIRCULATIONAHA.123.064346>10.1161/CIRCULATIONAHA.123.064346</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37486998</guid><pubDate> Mon, 24 Jul 2023 06:00:00 -0400</pubDate><dc:creator>米尔顿·帕克</dc:creator><dc:creator>克里斯托弗·威尔考克斯</dc:creator><dc:creator>杰弗里·M·泰斯塔尼</dc:creator><dc:date>2023-07-24</dc:date><dc:source>循环</dc:source><dc:title>SGLT2 抑制剂对肾小管钠、水和氯稳态的影​​响及其在影响心力衰竭结局中的作用的批判性分析</dc:title><dc:identifier>下午：37486998</dc:identifier><dc:identifier>管理中心：PMC10358443</dc:identifier><dc:identifier> doi:10.1161/循环AHA.123.064346</dc:identifier></item><item><title> FDA 现代化法案 2.0 为培养皿中的计算生物学和临床试验铺平了道路</title><link/>https://pubmed.ncbi.nlm.nih.gov/37486997/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff = 20230726085455&amp;v=2.17.9.post6+86293ac<description>没有摘要</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>流通</b>. 2023 年 7 月 25 日；148(4):309-311. doi: 10.1161/CIRCULATIONAHA.123.065585. Epub 2023 年 7 月 24 日。</p><p><b>无摘要</b></p><p style="color: lightgray">PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37486997/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230726085455&v=2.17.9.post6+86293ac">37486997</a> | DOI： <a href=https://doi.org/10.1161/CIRCULATIONAHA.123.065585>10.1161/循环AHA.123.065585</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37486997</guid><pubDate> Mon, 24 Jul 2023 06:00:00 -0400</pubDate><dc:creator>赛义德·穆赫塔尔·艾哈迈德</dc:creator><dc:creator>拉宾德拉 V 希夫纳拉因</dc:creator><dc:creator>约瑟夫·吴</dc:creator><dc:date>2023-07-24</dc:date><dc:source>循环</dc:source><dc:title>FDA 现代化法案 2.0 为培养皿中的计算生物学和临床试验铺平了道路</dc:title><dc:identifier>下午：37486997</dc:identifier><dc:identifier> doi:10.1161/循环AHA.123.065585</dc:identifier></item><item><title>含有四分之一剂量降压药物四重组合的单药丸初始治疗与标准剂量单药治疗对高血压患者动态血压指数的影响：来自 QUARTET 研究的结果</title><link/>https://pubmed.ncbi.nlm.nih.gov/37486996/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff = 20230726085455&amp;v=2.17.9.post6+86293ac<description>没有摘要</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>流通</b>. 2023 年 7 月 25 日；148(4):375-377. doi: 10.1161/CIRCULATIONAHA.123.064964. Epub 2023 年 7 月 24 日。</p><p><b>无摘要</b></p><p style="color: lightgray">PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37486996/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230726085455&v=2.17.9.post6+86293ac">37486996</a> | DOI： <a href=https://doi.org/10.1161/CIRCULATIONAHA.123.064964>10.1161/CIRCULATIONAHA.123.064964</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37486996</guid><pubDate> Mon, 24 Jul 2023 06:00:00 -0400</pubDate><dc:creator>贾尼斯·M·诺尔德</dc:creator><dc:creator>艾米丽·阿特金斯</dc:creator><dc:creator>西蒙娜·马施纳</dc:creator><dc:creator>格雷厄姆·希利斯</dc:creator><dc:creator>约翰·查默斯</dc:creator><dc:creator>洛朗·比约</dc:creator><dc:creator>马克·R·纳尔逊</dc:creator><dc:creator>——克里斯托弗·M·里德</dc:creator><dc:creator>彼得·海伊</dc:creator><dc:creator>迈克尔·伯克</dc:creator><dc:creator>雪莉詹森</dc:creator><dc:creator>——蒂姆·厄舍伍德</dc:creator><dc:creator>安东尼·罗杰斯</dc:creator><dc:creator>克拉拉·周</dc:creator><dc:creator>马库斯·P·施莱奇</dc:creator><dc:date>2023-07-24</dc:date><dc:source>循环</dc:source><dc:title>含有四分之一剂量降压药物四重组合的单药丸初始治疗与标准剂量单药治疗对高血压患者动态血压指数的影响：来自 QUARTET 研究的结果</dc:title><dc:identifier>下午：37486996</dc:identifier><dc:identifier> doi:10.1161/循环AHA.123.064964</dc:identifier></item><item><title> Vázquez 等人关于文章“阿哌沙班用于血液透析房颤患者：一项多中心随机对照试验”的信函</title><link/>https://pubmed.ncbi.nlm.nih.gov/37486995/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff = 20230726085455&amp;v=2.17.9.post6+86293ac<description>没有摘要</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>流通</b>. 2023 年 7 月 25 日；148(4):378. doi: 10.1161/CIRCULATIONAHA.122.063700. Epub 2023 年 7 月 24 日。</p><p><b>无摘要</b></p><p style="color: lightgray">PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37486995/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230726085455&v=2.17.9.post6+86293ac">37486995</a> | DOI： <a href=https://doi.org/10.1161/CIRCULATIONAHA.122.063700>10.1161 / CIRCULATIONAHA.122.063700</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37486995</guid><pubDate> Mon, 24 Jul 2023 06:00:00 -0400</pubDate><dc:creator>爱德华多·巴斯克斯</dc:creator><dc:creator>特蕾莎·巴斯克斯-桑切斯</dc:creator><dc:creator>卡门·桑切斯-佩拉莱斯</dc:creator><dc:date>2023-07-24</dc:date><dc:source>循环</dc:source><dc:title>Vázquez 等人关于文章“阿哌沙班用于血液透析房颤患者：一项多中心随机对照试验”的信函</dc:title><dc:identifier>下午：37486995</dc:identifier><dc:identifier> doi:10.1161/循环AHA.122.063700</dc:identifier></item><item><title>酷热和空气质量差：心血管健康的双重威胁</title><link/>https://pubmed.ncbi.nlm.nih.gov/37486994/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff = 20230726085455&amp;v=2.17.9.post6+86293ac<description>没有摘要</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>流通</b>. 2023 年 7 月 25 日；148(4):324-326. doi: 10.1161/CIRCULATIONAHA.123.065572. Epub 2023 年 7 月 24 日。</p><p><b>无摘要</b></p><p style="color: lightgray">PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37486994/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230726085455&v=2.17.9.post6+86293ac">37486994</a> | DOI： <a href=https://doi.org/10.1161/CIRCULATIONAHA.123.065572>10.1161/CIRCULATIONAHA.123.065572</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37486994</guid><pubDate> Mon, 24 Jul 2023 06:00:00 -0400</pubDate><dc:creator>萨米德·艾哈迈德·卡塔纳</dc:creator><dc:creator>——彼得·W·格罗内维尔德</dc:creator><dc:date>2023-07-24</dc:date><dc:source>循环</dc:source><dc:title>酷热和空气质量差：心血管健康的双重威胁</dc:title><dc:identifier>下午：37486994</dc:identifier><dc:identifier> doi:10.1161/循环AHA.123.065572</dc:identifier></item><item><title>极端温度事件、细颗粒物和心肌梗塞死亡率</title><link/>https://pubmed.ncbi.nlm.nih.gov/37486993/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff = 20230726085455&amp;v=2.17.9.post6+86293ac<description>结论：这项研究提供了一致的证据，表明接触 ETE 和 PM(2.5) 与 MI 死亡率增加显着相关，特别是对于女性和老年人而言，并且热浪与 PM(2.5) 协同相互作用可引发 MI 死亡但寒潮则不然。我们的研究结果表明，减少 ETE 和 PM(2.5) 暴露可能会带来健康益处，有助于预防因心肌梗死导致的过早死亡。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>流通</b>. 2023 年 7 月 25 日；148(4):312-323.doi: 10.1161/CIRCULATIONAHA.122.063504. Epub 2023 年 7 月 24 日。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">背景：极端温度事件 (ETE)，包括热浪和寒潮，已与心肌梗死 (MI) 发病率相关；然而，它们对 MI 死亡率的影响尚不清楚。尽管建议环境细颗粒物 (PM <sub>2.5</sub> )虽然 ETE 和 PM 2.5 与极端温度对心血管死亡率具有协同作用，但目前尚不清楚 ETE 和 PM <sub>2.5</sub>是否以及如何相互作用引发 MI 死亡。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：对中国江苏省2015年至2020年202 678例心肌梗死死亡进行时间分层病例交叉研究，探讨ETE和PM <sub>2.5</sub>暴露与心肌梗死死亡率的关系，并评估其交互作用。使用环境表观温度、多个温度阈值和持续时间来构建 12 个 ETE 定义。通过从每个受试者的地理编码居住地址的经过验证的网格数据集中提取值来评估每日 ETE 和 PM <sub>2.5</sub>暴露。应用条件逻辑回归模型来执行暴露-响应分析并估计由于相互作用而导致的相对超额赔率、可归因于相互作用的比例以及协同指数。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：在不同的 ETE 定义下，与热浪和寒潮相关的 MI 死亡率的比值比范围为 1.18（95% CI，1.14-1.21）至 1.74（1.66-1.83）和 1.04（1.02-1.06）至 1.12（ 1.07-1.18），分别。滞后 01 天暴露于 PM <sub>2.5</sub>与 MI 死亡率增加显着相关，暴露量越高，死亡率就越低。我们观察到热浪和 PM <sub>2.5</sub>对 MI 死亡率有显着的协同作用（相对由于相互作用 >; 0 导致的超额赔率、相互作用 >; 0 的比例以及协同指数 >; 1），一般来说，对于强度更大、持续时间更长的热浪来说，这一比例更高。我们估计，高达 2.8% 的 MI 死亡归因于接触 ETE 和 PM <sub>2.5</sub>的水平超过了世界卫生组织空气质量指南的临时目标 3 值 (37.5 μg/m <sup>3</sup> )。女性和老年人更容易受到 ETE 和 PM <sub>2.5</sub>的影响。PM <sub>2.5</sub>对 MI 死亡率的影响不因性别、年龄或社会经济地位而异。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：这项研究提供了一致的证据，表明暴露于 ETE 和 PM <sub>2.5</sub>与 MI 死亡率增加显着相关，特别是对于女性和老年人而言，并且热浪与 PM <sub>2.5</sub>协同相互作用可引发 MI 死亡，但寒潮会引发 MI 死亡。我们的研究结果表明，减少 ETE 和 PM <sub>2.5</sub>暴露可能会给健康带来好处，预防 MI 导致的过早死亡。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37486993/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230726085455&v=2.17.9.post6+86293ac">37486993</a> | DOI： <a href=https://doi.org/10.1161/CIRCULATIONAHA.122.063504>10.1161/CIRCULATIONAHA.122.063504</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37486993</guid><pubDate> Mon, 24 Jul 2023 06:00:00 -0400</pubDate><dc:creator>徐瑞军</dc:creator><dc:creator>黄素丽</dc:creator><dc:creator>施春香</dc:creator><dc:creator>王锐</dc:creator><dc:creator>刘婷婷</dc:creator><dc:creator>李迎新</dc:creator><dc:creator>郑毅</dc:creator><dc:creator>紫泉Lv.</dc:creator><dc:creator>静伟</dc:creator><dc:creator>孙红</dc:creator><dc:creator>刘跃伟</dc:creator><dc:date>2023-07-24</dc:date><dc:source>循环</dc:source><dc:title>极端温度事件、细颗粒物和心肌梗塞死亡率</dc:title><dc:identifier>下午：37486993</dc:identifier><dc:identifier> doi:10.1161/循环AHA.122.063504</dc:identifier></item><item><title>运动引起的胸痛：缺血或其他原因</title><link/>https://pubmed.ncbi.nlm.nih.gov/37486992/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff = 20230726085455&amp;v=2.17.9.post6+86293ac<description>没有摘要</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>流通</b>. 2023 年 7 月 25 日；148(4):373-374. doi: 10.1161/CIRCULATIONAHA.123.065262. Epub 2023 年 7 月 24 日。</p><p><b>无摘要</b></p><p style="color: lightgray">PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37486992/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230726085455&v=2.17.9.post6+86293ac">37486992</a> | DOI： <a href=https://doi.org/10.1161/CIRCULATIONAHA.123.065262>10.1161/CIRCULATIONAHA.123.065262</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37486992</guid><pubDate> Mon, 24 Jul 2023 06:00:00 -0400</pubDate><dc:creator>尹兆伟</dc:creator><dc:creator>段江波</dc:creator><dc:date>2023-07-24</dc:date><dc:source>循环</dc:source><dc:title>运动引起的胸痛：缺血或其他原因</dc:title><dc:identifier>下午：37486992</dc:identifier><dc:identifier> doi:10.1161/循环AHA.123.065262</dc:identifier></item><item><title>欧洲药品管理局对 mavacamten 治疗成年患者症状性梗阻性肥厚性心肌病的评估</title><link/>https://pubmed.ncbi.nlm.nih.gov/37482673/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff = 20230726085455&amp;v=2.17.9.post6+86293ac<description>没有摘要</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Eur Heart J. 2023 Jul 24:ehad429.doi: 10.1093/eurheartj/ehad429. 印刷前在线。</p><p><b>无摘要</b></p><p style="color: lightgray">PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37482673/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230726085455&v=2.17.9.post6+86293ac">37482673</a> | DOI： <a href=https://doi.org/10.1093/eurheartj/ehad429>10.1093/eurheartj/ehad429</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37482673</guid><pubDate> Mon, 24 Jul 2023 06:00:00 -0400</pubDate><dc:creator> J·汉斯·德弗里斯</dc:creator><dc:creator>阿拉尔税务局</dc:creator><dc:creator>汉斯·L·希勒奇</dc:creator><dc:date>2023-07-24</dc:date><dc:source>欧洲心脏杂志</dc:source><dc:title>欧洲药品管理局对 mavacamten 治疗成年患者症状性梗阻性肥厚性心肌病的评估</dc:title><dc:identifier>下午：37482673</dc:identifier><dc:identifier> doi:10.1093/eurheartj/ehad429</dc:identifier></item><item><title> 2023 年 AHA/ACC/ACCP/ASPC/NLA/PCNA 慢性冠心病患者管理指南：美国心脏协会/美国心脏病学会临床实践指南联合委员会报告</title><link/>https://pubmed.ncbi.nlm.nih.gov/37480922/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230726085455&amp;v=2.17.9.post6+86293ac<description> AIM: The &quot;2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease&quot; provides an update to and consolidates new evidence since the &quot;2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease&quot; and the corresponding &quot;2014 ACC/AHA/AATS/PCNA/SCAI/STS Focused Update of the Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease.&quot; </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> J Am Coll Cardiol. 2023 Jul 14:S0735-1097(23)05281-6. doi: 10.1016/j.jacc.2023.04.003. Online ahead of print.</p><p> <b>ABSTRACT</b> </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> AIM: The &quot;2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease&quot; provides an update to and consolidates new evidence since the &quot;2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease&quot; and the corresponding &quot;2014 ACC/AHA/AATS/PCNA/SCAI/STS Focused Update of the Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease.&quot; </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> METHODS: A comprehensive literature search was conducted from September 2021 to May 2022. Clinical studies, systematic reviews and meta-analyses, and other evidence conducted on human participants were identified that were published in English from MEDLINE (through PubMed), EMBASE, the Cochrane Library, Agency for Healthcare Research and Quality, and other selected databases relevant to this guideline. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> STRUCTURE: This guideline provides an evidenced-based and patient-centered approach to management of patients with chronic coronary disease, considering social determinants of health and incorporating the principles of shared decision-making and team-based care. Relevant topics include general approaches to treatment decisions, guideline-directed management and therapy to reduce symptoms and future cardiovascular events, decision-making pertaining to revascularization in patients with chronic coronary disease, recommendations for management in special populations, patient follow-up and monitoring, evidence gaps, and areas in need of future research. Where applicable, and based on availability of cost-effectiveness data, cost-value recommendations are also provided for clinicians. Many recommendations from previously published guidelines have been updated with new evidence, and new recommendations have been created when supported by published data.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37480922/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230726085455&v=2.17.9.post6+86293ac">37480922</a> | DOI: <a href=https://doi.org/10.1016/j.jacc.2023.04.003>10.1016/j.jacc.2023.04.003</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:37480922</guid><pubDate> Sat, 22 Jul 2023 06:00:00 -0400</pubDate><dc:creator> Writing Committee Members</dc:creator><dc:creator> Salim S Virani</dc:creator><dc:creator> L Kristin Newby</dc:creator><dc:creator> Suzanne V Arnold</dc:creator><dc:creator> Vera Bittner</dc:creator><dc:creator> LaPrincess C Brewer</dc:creator><dc:creator> Susan Halli Demeter</dc:creator><dc:creator> Dave L Dixon</dc:creator><dc:creator> William F Fearon</dc:creator><dc:creator> Beverly Hess</dc:creator><dc:creator> Heather M Johnson</dc:creator><dc:creator> Dhruv S Kazi</dc:creator><dc:creator> Dhaval Kolte</dc:creator><dc:creator> Dharam J Kumbhani</dc:creator><dc:creator> Jim LoFaso</dc:creator><dc:creator> Dhruv Mahtta</dc:creator><dc:creator> Daniel B Mark</dc:creator><dc:creator> Margo Minissian</dc:creator><dc:creator> Ann Marie Navar</dc:creator><dc:creator> Amit R Patel</dc:creator><dc:creator> Mariann R Piano</dc:creator><dc:creator> Fatima Rodriguez</dc:creator><dc:creator> Amy W Talbot</dc:creator><dc:creator> Viviany R Taqueti</dc:creator><dc:creator> Randal J Thomas</dc:creator><dc:creator> Sean van Diepen</dc:creator><dc:creator> Barbara Wiggins</dc:creator><dc:creator> Marlene S Williams</dc:creator><dc:date> 2023-07-22</dc:date><dc:source> Journal of the American College of Cardiology</dc:source><dc:title> 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines</dc:title><dc:identifier> pmid:37480922</dc:identifier><dc:identifier> doi:10.1016/j.jacc.2023.04.003</dc:identifier></item><item><title> 2023 Chronic Coronary Disease Guideline-at-a-Glance</title><link/> https://pubmed.ncbi.nlm.nih.gov/37480921/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230726085455&amp;v=2.17.9.post6+86293ac<description> No abstract </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> J Am Coll Cardiol. 2023 Jul 14:S0735-1097(23)05906-5. doi: 10.1016/j.jacc.2023.06.006. Online ahead of print.</p><p> <b>NO ABSTRACT</b></p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37480921/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230726085455&v=2.17.9.post6+86293ac">37480921</a> | DOI: <a href=https://doi.org/10.1016/j.jacc.2023.06.006>10.1016/j.jacc.2023.06.006</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:37480921</guid><pubDate> Sat, 22 Jul 2023 06:00:00 -0400</pubDate><dc:creator> David E Winchester</dc:creator><dc:creator> ACC Solution Set Oversight Committee</dc:creator><dc:date> 2023-07-22</dc:date><dc:source> Journal of the American College of Cardiology</dc:source><dc:title> 2023 Chronic Coronary Disease Guideline-at-a-Glance</dc:title><dc:identifier> pmid:37480921</dc:identifier><dc:identifier> doi:10.1016/j.jacc.2023.06.006</dc:identifier></item><item><title> Mechanism of orphan subunit recognition during assembly quality control</title><link/> https://pubmed.ncbi.nlm.nih.gov/37480851/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230726085455&amp;v=2.17.9.post6+86293ac<description> Cells contain numerous abundant molecular machines assembled from multiple subunits. Imbalances in subunit production and failed assembly generate orphan subunits that are eliminated by poorly defined pathways. Here, we determined how orphan subunits of the cytosolic chaperonin CCT are recognized. Several unassembled CCT subunits recruited the E3 ubiquitin ligase HERC2 using ZNRD2 as an adaptor. Both factors were necessary for orphan CCT subunit degradation in cells, sufficient for CCT subunit... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> <b>Cell</b> . 2023 Jul 19:S0092-8674(23)00694-3. doi: 10.1016/j.cell.2023.06.016. Online ahead of print.</p><p> <b>ABSTRACT</b> </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> Cells contain numerous abundant molecular machines assembled from multiple subunits. Imbalances in subunit production and failed assembly generate orphan subunits that are eliminated by poorly defined pathways. Here, we determined how orphan subunits of the cytosolic chaperonin CCT are recognized. Several unassembled CCT subunits recruited the E3 ubiquitin ligase HERC2 using ZNRD2 as an adaptor. Both factors were necessary for orphan CCT subunit degradation in cells, sufficient for CCT subunit ubiquitination with purified factors, and necessary for optimal cell fitness. Domain mapping and structure prediction defined the molecular features of a minimal HERC2-ZNRD2-CCT module. The structural model, whose key elements were validated in cells using point mutants, shows why ZNRD2 selectively recognizes multiple orphaned CCT subunits without engaging assembled CCT. Our findings reveal how failures during CCT assembly are monitored and provide a paradigm for the molecular recognition of orphan subunits, the largest source of quality control substrates in cells.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37480851/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230726085455&v=2.17.9.post6+86293ac">37480851</a> | DOI: <a href=https://doi.org/10.1016/j.cell.2023.06.016>10.1016/j.cell.2023.06.016</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:37480851</guid><pubDate> Sat, 22 Jul 2023 06:00:00 -0400</pubDate><dc:creator> Yuichi Yagita</dc:creator><dc:creator> Eszter Zavodszky</dc:creator><dc:creator> Sew-Yeu Peak-Chew</dc:creator><dc:creator> Ramanujan S Hegde</dc:creator><dc:date> 2023-07-22</dc:date><dc:source> Cell</dc:source><dc:title> Mechanism of orphan subunit recognition during assembly quality control</dc:title><dc:identifier> pmid:37480851</dc:identifier><dc:identifier> doi:10.1016/j.cell.2023.06.016</dc:identifier></item><item><title> Ultrafast distant wound response is essential for whole-body regeneration</title><link/> https://pubmed.ncbi.nlm.nih.gov/37480850/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230726085455&amp;v=2.17.9.post6+86293ac<description> Injury induces systemic responses, but their functions remain elusive. Mechanisms that can rapidly synchronize wound responses through long distances are also mostly unknown. Using planarian flatworms capable of whole-body regeneration, we report that injury induces extracellular signal-regulated kinase (Erk) activity waves to travel at a speed 10-100 times faster than those in other multicellular tissues. This ultrafast propagation requires longitudinal body-wall muscles, elongated cells... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> <b>Cell</b> . 2023 Jul 16:S0092-8674(23)00695-5. doi: 10.1016/j.cell.2023.06.019. Online ahead of print.</p><p> <b>ABSTRACT</b> </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> Injury induces systemic responses, but their functions remain elusive. Mechanisms that can rapidly synchronize wound responses through long distances are also mostly unknown. Using planarian flatworms capable of whole-body regeneration, we report that injury induces extracellular signal-regulated kinase (Erk) activity waves to travel at a speed 10-100 times faster than those in other multicellular tissues. This ultrafast propagation requires longitudinal body-wall muscles, elongated cells forming dense parallel tracks running the length of the organism. The morphological properties of muscles allow them to act as superhighways for propagating and disseminating wound signals. Inhibiting Erk propagation prevents tissues distant to the wound from responding and blocks regeneration, which can be rescued by a second injury to distal tissues shortly after the first injury. Our findings provide a mechanism for long-range signal propagation in large, complex tissues to coordinate responses across cell types and highlight the function of feedback between spatially separated tissues during whole-body regeneration.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37480850/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230726085455&v=2.17.9.post6+86293ac">37480850</a> | DOI: <a href=https://doi.org/10.1016/j.cell.2023.06.019>10.1016/j.cell.2023.06.019</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:37480850</guid><pubDate> Sat, 22 Jul 2023 06:00:00 -0400</pubDate><dc:creator> Yuhang Fan</dc:creator><dc:creator> Chew Chai</dc:creator><dc:creator> Pengyang Li</dc:creator><dc:creator> Xinzhi Zou</dc:creator><dc:creator> James E Ferrell</dc:creator><dc:creator> Bo Wang</dc:creator><dc:date> 2023-07-22</dc:date><dc:source> Cell</dc:source><dc:title> Ultrafast distant wound response is essential for whole-body regeneration</dc:title><dc:identifier> pmid:37480850</dc:identifier><dc:identifier> doi:10.1016/j.cell.2023.06.019</dc:identifier></item><item><title> Orphan quality control shapes network dynamics and gene expression</title><link/> https://pubmed.ncbi.nlm.nih.gov/37478862/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230726085455&amp;v=2.17.9.post6+86293ac<description> All eukaryotes require intricate protein networks to translate developmental signals into accurate cell fate decisions. Mutations that disturb interactions between network components often result in disease, but how the composition and dynamics of complex networks are established remains poorly understood. Here, we identify the E3 ligase UBR5 as a signaling hub that helps degrade unpaired subunits of multiple transcriptional regulators that act within a network centered on the c-Myc oncoprotein.... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> <b>Cell</b> . 2023 Jul 14:S0092-8674(23)00691-8. doi: 10.1016/j.cell.2023.06.015. Online ahead of print.</p><p> <b>ABSTRACT</b> </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> All eukaryotes require intricate protein networks to translate developmental signals into accurate cell fate decisions. Mutations that disturb interactions between network components often result in disease, but how the composition and dynamics of complex networks are established remains poorly understood. Here, we identify the E3 ligase UBR5 as a signaling hub that helps degrade unpaired subunits of multiple transcriptional regulators that act within a network centered on the c-Myc oncoprotein. Biochemical and structural analyses show that UBR5 binds motifs that only become available upon complex dissociation. By rapidly turning over unpaired transcription factor subunits, UBR5 establishes dynamic interactions between transcriptional regulators that allow cells to effectively execute gene expression while remaining receptive to environmental signals. We conclude that orphan quality control plays an essential role in establishing dynamic protein networks, which may explain the conserved need for protein degradation during transcription and offers opportunities to modulate gene expression in disease.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37478862/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230726085455&v=2.17.9.post6+86293ac">37478862</a> | DOI: <a href=https://doi.org/10.1016/j.cell.2023.06.015>10.1016/j.cell.2023.06.015</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:37478862</guid><pubDate> Fri, 21 Jul 2023 06:00:00 -0400</pubDate><dc:creator> Kevin G Mark</dc:creator><dc:creator> SriDurgaDevi Kolla</dc:creator><dc:creator> Jacob D Aguirre</dc:creator><dc:creator> Danielle M Garshott</dc:creator><dc:creator> Stefan Schmitt</dc:creator><dc:creator> Diane L Haakonsen</dc:creator><dc:creator> Christina Xu</dc:creator><dc:creator> Lukas Kater</dc:creator><dc:creator> Georg Kempf</dc:creator><dc:creator> Brenda Martínez-González</dc:creator><dc:creator> David Akopian</dc:creator><dc:creator> Stephanie K See</dc:creator><dc:creator> Nicolas H Thomä</dc:creator><dc:creator> Michael Rapé</dc:creator><dc:date> 2023-07-21</dc:date><dc:source> Cell</dc:source><dc:title> Orphan quality control shapes network dynamics and gene expression</dc:title><dc:identifier> pmid:37478862</dc:identifier><dc:identifier> doi:10.1016/j.cell.2023.06.015</dc:identifier></item><item><title> Modeling post-implantation stages of human development into early organogenesis with stem-cell-derived peri-gastruloids</title><link/> https://pubmed.ncbi.nlm.nih.gov/37478861/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230726085455&amp;v=2.17.9.post6+86293ac<description> In vitro stem cell models that replicate human gastrulation have been generated, but they lack the essential extraembryonic cells needed for embryonic development, morphogenesis, and patterning. Here, we describe a robust and efficient method that prompts human extended pluripotent stem cells to self-organize into embryo-like structures, termed peri-gastruloids, which encompass both embryonic (epiblast) and extraembryonic (hypoblast) tissues. Although peri-gastruloids are not viable due to the... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> <b>Cell</b> . 2023 Jul 19:S0092-8674(23)00794-8. doi: 10.1016/j.cell.2023.07.018. Online ahead of print.</p><p> <b>ABSTRACT</b> </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> In vitro stem cell models that replicate human gastrulation have been generated, but they lack the essential extraembryonic cells needed for embryonic development, morphogenesis, and patterning. Here, we describe a robust and efficient method that prompts human extended pluripotent stem cells to self-organize into embryo-like structures, termed peri-gastruloids, which encompass both embryonic (epiblast) and extraembryonic (hypoblast) tissues. Although peri-gastruloids are not viable due to the exclusion of trophoblasts, they recapitulate critical stages of human peri-gastrulation development, such as forming amniotic and yolk sac cavities, developing bilaminar and trilaminar embryonic discs, specifying primordial germ cells, initiating gastrulation, and undergoing early neurulation and organogenesis. Single-cell RNA-sequencing unveiled transcriptomic similarities between advanced human peri-gastruloids and primary peri-gastrulation cell types found in humans and non-human primates. This peri-gastruloid platform allows for further exploration beyond gastrulation and may potentially aid in the development of human fetal tissues for use in regenerative medicine.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37478861/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230726085455&v=2.17.9.post6+86293ac">37478861</a> | DOI: <a href=https://doi.org/10.1016/j.cell.2023.07.018>10.1016/j.cell.2023.07.018</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:37478861</guid><pubDate> Fri, 21 Jul 2023 06:00:00 -0400</pubDate><dc:creator> Lizhong Liu</dc:creator><dc:creator> Seiya Oura</dc:creator><dc:creator> Zachary Markham</dc:creator><dc:creator> James N Hamilton</dc:creator><dc:creator> Robin M Skory</dc:creator><dc:creator> Leijie Li</dc:creator><dc:creator> Masahiro Sakurai</dc:creator><dc:creator> Lei Wang</dc:creator><dc:creator> Carlos A Pinzon-Arteaga</dc:creator><dc:creator> Nicolas Plachta</dc:creator><dc:creator> Gary C Hon</dc:creator><dc:creator> Jun Wu</dc:creator><dc:date> 2023-07-21</dc:date><dc:source> Cell</dc:source><dc:title> Modeling post-implantation stages of human development into early organogenesis with stem-cell-derived peri-gastruloids</dc:title><dc:identifier> pmid:37478861</dc:identifier><dc:identifier> doi:10.1016/j.cell.2023.07.018</dc:identifier></item></channel></rss>